These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8617573)
1. Investigation of the comparative effects of 2-chlorodeoxyadenosine on tumor colony forming units in vitro. Depenbrock H; Wenger M; Peter R; Fellbaum C; Block T; Rastetter J; Hanauske AR Invest New Drugs; 1995; 13(2):117-23. PubMed ID: 8617573 [TBL] [Abstract][Full Text] [Related]
2. Activity of NK 611, a new epipodophyllotoxin derivative, against colony forming units from freshly explanted human tumours in vitro. Hanauske AR; Wüster KC; Lehmer A; Rotter M; Schneider P; Kaeser-Fröhlich A; Rastetter J; Depenbrock H Eur J Cancer; 1995 Sep; 31A(10):1677-81. PubMed ID: 7488424 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of 5'-nor-anhydrovinblastine (vinorelbine), against freshly explanted clonogenic human tumor cells in vitro. Djuanda I; Depenbrock H; Peter R; Block T; Pohlmann G; Rastetter J; Hanauske AR Invest New Drugs; 1996; 14(2):153-9. PubMed ID: 8913836 [TBL] [Abstract][Full Text] [Related]
4. Preclinical activity of trans-indazolium[tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cells. Depenbrock H; Schmelcher S; Peter R; Keppler BK; Weirich G; Block T; Rastetter J; Hanauske AR Eur J Cancer; 1997 Dec; 33(14):2404-10. PubMed ID: 9616290 [TBL] [Abstract][Full Text] [Related]
5. Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: comparison with taxol and conventional antineoplastic agents. Vogel M; Hilsenbeck SG; Depenbrock H; Danhauser-Riedl S; Block T; Nekarda H; Fellbaum C; Aapro MS; Bissery MC; Rastetter J Eur J Cancer; 1993; 29A(14):2009-14. PubMed ID: 7904173 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model. Guchelaar HJ; Vermes I; Koopmans RP; Reutelingsperger CP; Haanen C Cancer Chemother Pharmacol; 1998; 42(1):77-83. PubMed ID: 9619762 [TBL] [Abstract][Full Text] [Related]
7. Activity of intoplicine (RP60475), a new DNA topoisomerase I and II inhibitor, against human tumor colony-forming units in vitro. Eckardt JR; Burris HA; Kuhn JG; Bissery MC; Klink-Alakl M; Clark GM; Von Hoff DD J Natl Cancer Inst; 1994 Jan; 86(1):30-3. PubMed ID: 8271279 [TBL] [Abstract][Full Text] [Related]
8. The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro. Korycka A; Robak T Leuk Lymphoma; 2003 Sep; 44(9):1549-55. PubMed ID: 14565659 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumours. Larsson R; Fridborg H; Liliemark J; Csoka K; Kristensen J; de la Torre M; Nygren P Eur J Cancer; 1994; 30A(7):1022-6. PubMed ID: 7946567 [TBL] [Abstract][Full Text] [Related]
10. Activity of the morpholino anthracycline 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin (MX2) against human tumor colony-forming units in vitro. Ebrahim el-Zayat AA; Izquierdo MA; Clark GM; Von Hoff DD Invest New Drugs; 1995; 13(2):125-131. PubMed ID: 8617574 [TBL] [Abstract][Full Text] [Related]
11. Activity of temozolomide against human tumor colony-forming units. Raymond E; Izbicka E; Soda H; Gerson SL; Dugan M; Von Hoff DD Clin Cancer Res; 1997 Oct; 3(10):1769-74. PubMed ID: 9815562 [TBL] [Abstract][Full Text] [Related]
12. Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro. Burris HA; Hanauske AR; Johnson RK; Marshall MH; Kuhn JG; Hilsenbeck SG; Von Hoff DD J Natl Cancer Inst; 1992 Dec; 84(23):1816-20. PubMed ID: 1331485 [TBL] [Abstract][Full Text] [Related]
13. A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors. Weiss GR; Kuhn JG; Rizzo J; Smith LS; Rodriguez GI; Eckardt JR; Burris HA; Fields S; VanDenBerg K; von Hoff DD Cancer Chemother Pharmacol; 1995; 35(5):397-402. PubMed ID: 7850921 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors. Csoka K; Liliemark J; Larsson R; Nygren P Semin Oncol; 1995 Aug; 22(4 Suppl 11):47-53. PubMed ID: 7481845 [TBL] [Abstract][Full Text] [Related]
15. [Human tumor clonogenic assay in human breast cancer]. Kobayashi T; Kuraishi Y; Aiba K; Inoue K Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846 [TBL] [Abstract][Full Text] [Related]
16. Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units. Petit T; Izbicka E; Lawrence RA; Bishop WR; Weitman S; Von Hoff DD Ann Oncol; 1999 Apr; 10(4):449-53. PubMed ID: 10370788 [TBL] [Abstract][Full Text] [Related]
17. Activity of oxaliplatin against human tumor colony-forming units. Raymond E; Lawrence R; Izbicka E; Faivre S; Von Hoff DD Clin Cancer Res; 1998 Apr; 4(4):1021-9. PubMed ID: 9563898 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units. Hidalgo M; Izbicka E; Eckhardt SG; MacDonald JR; Cerna C; Gomez L; Rowinsky EK; Weitman SD; Von Hoff DD Anticancer Drugs; 1999 Oct; 10(9):837-44. PubMed ID: 10587294 [TBL] [Abstract][Full Text] [Related]
19. Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia. Kristensen J; Nygren P; Liliemark J; Fridborg H; Killander A; Simonsson B; Oberg G; Larsson R Leukemia; 1994 Oct; 8(10):1712-7. PubMed ID: 7934168 [TBL] [Abstract][Full Text] [Related]
20. [Effect of 2-chlorodeoxyadenosine, arabinoside cytosine and doxorubicin on acute myeloid leukemia clonogenic cell proliferation]. Sawiński K; Hansz J; Kozłowska-Skrzypczak M Acta Haematol Pol; 1995; 26(3):279-84. PubMed ID: 8525773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]